tazarotene has been researched along with minocycline in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Leyden, J; Shalita, AR; Shupack, J; Strober, BE; Thiboutot, DM; Washenik, K; Webster, G | 1 |
| Bikowski, J; Callender, VD; Del Rosso, JQ; Draelos, ZD; Tanghetti, E | 1 |
| Agero, AL; Dusza, SW; Halpern, AC; Kemeny, NE; Lieb, JA; Myskowski, PL; Saltz, L; Scope, A | 1 |
| Tseng, HH; Tseng, HW; Wu, CS | 1 |
| Chan, KF; Chen, X; Evans, CL; Greenfield, DA; Hermsmeier, M; Jeong, S; Yamamoto, A | 1 |
2 trial(s) available for tazarotene and minocycline
| Article | Year |
|---|---|
Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.
Topics: Acne Vulgaris; Administration, Oral; Adult; Anti-Bacterial Agents; Dermatologic Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Minocycline; Nicotinic Acids; Severity of Illness Index; Treatment Outcome; United States | 2006 |
Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption.
Topics: Acneiform Eruptions; Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Colorectal Neoplasms; Dermatologic Agents; Double-Blind Method; ErbB Receptors; Female; Humans; Male; Middle Aged; Minocycline; Nicotinic Acids; Placebos | 2007 |
4 other study(ies) available for tazarotene and minocycline
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Keratolytic Agents; Male; Minocycline; Naphthalenes; Nicotinic Acids; Retinoids; Treatment Outcome; Tretinoin | 2006 |
Confluent and reticulate papillomatosis treated with minocycline and tazarotene.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Anti-Bacterial Agents; Dermatologic Agents; Female; Follow-Up Studies; Humans; Male; Minocycline; Nicotinic Acids; Papilloma; Skin Neoplasms; Treatment Outcome; Young Adult | 2013 |
Time-resolved fluorescence microscopy with phasor analysis for visualizing multicomponent topical drug distribution within human skin.
Topics: Administration, Topical; Algorithms; Dermatologic Agents; Drug Combinations; Face; Fluorescence; Gels; Humans; Image Processing, Computer-Assisted; Microscopy, Fluorescence; Minocycline; Molecular Imaging; Nicotinic Acids; Skin; Spectrometry, Fluorescence | 2020 |